MF-018 - Non-opioid Pain Medication | Approved by Ministry of Health and Welfare project - 2017
Targeting pain with a non-opioid solution:
*A different approach to pain relief for chemotherapy patients
*Naturally derived compounds for pain relief
For mo
Aducanumab, the latest drug approved by the FDA for the treatment of Alzheimer'sis estimated to cost $56,000 annually. According to the New York Times, "There’s little evidence that the drug, Aduhelm, slows the progression of dementia, but the Food and Dr
Brain One is a naturally derived supplement made from a combination of extracts to improve memory %26 concentration. Combining the natural compounds with four-year-aged Korean ginseng boosts the immune system, enhances platelet count, and increases blood
